Not available
Quote | AMAG Pharmaceuticals Inc. (NASDAQ:AMAG)
Last: | $13.75 |
---|---|
Change Percent: | 0.15% |
Open: | $13.75 |
Close: | $13.75 |
High: | $13.76 |
Low: | $13.75 |
Volume: | 1,534,573 |
Last Trade Date Time: | 11/13/2020 04:56:03 pm |
News | AMAG Pharmaceuticals Inc. (NASDAQ:AMAG)
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...
Merger activity increased last week with four new deals announced. The acquisition of HD Supply Holdings by The Home Depot. The acquisition of Foundation Building Materials by American Securities. For further details see: Merger Arbitrage Mondays - Home Depot B...
Message Board Posts | AMAG Pharmaceuticals Inc. (NASDAQ:AMAG)
Subject | By | Source | When |
---|---|---|---|
Back to the $9s in the morning lol | T695 | investorshub | 09/30/2020 11:11:21 PM |
Rumors of buyout with Clovis | beachlover | investorshub | 09/30/2020 9:13:01 PM |
Nothing been posted here for a while but | Abdullah10 | investorshub | 09/30/2020 8:43:46 PM |
Insider Transactions | xgin | investorshub | 02/02/2020 9:29:50 PM |
* * $AMAG Video Chart 01-24-2020 * * | ClayTrader | investorshub | 01/24/2020 9:17:52 PM |
News, Short Squeeze, Breakout and More Instantly...
AMAG Pharmaceuticals Inc. Company Name:
AMAG Stock Symbol:
NASDAQ Market:
AMAG Pharmaceuticals Inc. Website:
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...
MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600 MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&...
WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena ® , the only F...